TSW
Thompson Siegel & Walmsley’s SPDR S&P Biotech ETF XBI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $663K | Sell |
8,000
-200
| -2% | -$16.6K | 0.01% | 318 |
|
|
2025
Q1 | $665K | Hold |
8,200
| – | – | 0.01% | 309 |
|
|
2024
Q4 | $738K | Sell |
8,200
-1,350
| -14% | -$122K | 0.01% | 295 |
|
|
2024
Q3 | $944K | Hold |
9,550
| – | – | 0.01% | 292 |
|
|
2024
Q2 | $885K | Sell |
9,550
-25
| -0.3% | -$2.32K | 0.01% | 278 |
|
|
2024
Q1 | $909K | Hold |
9,575
| – | – | 0.01% | 282 |
|
|
2023
Q4 | $855K | Hold |
9,575
| – | – | 0.01% | 277 |
|
|
2023
Q3 | $699K | Hold |
9,575
| – | – | 0.01% | 286 |
|
|
2023
Q2 | $797K | Hold |
9,575
| – | – | 0.01% | 284 |
|
|
2023
Q1 | $730K | Hold |
9,575
| – | – | 0.01% | 284 |
|
|
2022
Q4 | $795K | Hold |
9,575
| – | – | 0.01% | 266 |
|
|
2022
Q3 | $759K | Hold |
9,575
| – | – | 0.01% | 272 |
|
|
2022
Q2 | $711K | Hold |
9,575
| – | – | 0.01% | 281 |
|
|
2022
Q1 | $861K | Hold |
9,575
| – | – | 0.01% | 277 |
|
|
2021
Q4 | $1.07M | Hold |
9,575
| – | – | 0.01% | 262 |
|
|
2021
Q3 | $1.2M | Hold |
9,575
| – | – | 0.02% | 256 |
|
|
2021
Q2 | $1.3M | Buy |
9,575
+1,000
| +12% | +$135K | 0.02% | 257 |
|
|
2021
Q1 | $1.16M | Buy |
8,575
+7,575
| +758% | +$1.03M | 0.02% | 240 |
|
|
2020
Q4 | $141K | Buy |
1,000
+985
| +6,567% | +$139K | ﹤0.01% | 356 |
|
|
2020
Q3 | $2K | Hold |
15
| – | – | ﹤0.01% | 633 |
|
|
2020
Q2 | $2K | Buy |
+15
| New | +$2K | ﹤0.01% | 640 |
|